3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Sarcoma
37
Leiomyosarcoma
12
Liposarcoma
10
Sarcoma, Ewing
4
Neoplasms
4
Liposarcoma, Myxoid
4
Sarcoma, Synovial
3
Rhabdomyosarcoma
3
Histiocytoma, Malignant Fibrous
3
Sarcoma, Alveolar Soft Part
2
Ovarian Neoplasms
2
Osteosarcoma
2
Neurofibrosarcoma
2
Malignant mesenchymal tumor
2
Ichthyosis, X-Linked
2
Hemangiosarcoma
2
Hemangiopericytoma, Malignant
2
Fibrosarcoma
2
Bone Neoplasms
2
Wilms Tumor
1
Solitary Fibrous Tumors
1
Sarcoma, Endometrial Stromal
1
Neuroectodermal Tumors, Primitive, Peripheral
1
Neuroblastoma
1
Neoplasms, Connective and Soft Tissue
1
Neoplasms by Histologic Type
1
Neoplasm Metastasis
1
Lung Neoplasms
1
Leiomyosarcoma Uterus
1
Hemangioendothelioma
1
Interventions
Ifosfamide
5
Filgrastim
5
Doxorubicin
5
Gemcitabine
4
Docetaxel
4
Radiotherapy
3
Proton Therapy
3
Carboplatin
3
regorafenib
2
ivosidenib
2
enasidenib
2
belinostat
2
Sunitinib
2
Peripheral Blood Stem Cell Transplantation
2
Nivolumab
2
Immune Checkpoint Inhibitors
2
HhAntag691
2
Fluorouracil
2
Etoposide
2
Epirubicin
2
Cyclophosphamide
2
Cisplatin
2
Chemotherapy, Adjuvant
2
Celecoxib
2
Bevacizumab
2
venetoclax
1
toripalimab
1
temsirolimus
1
tazemetostat
1
tanespimycin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Chondrosarcoma
×
Trabectedin
×
Sarcoma
×
Clear all
NCT05131386
2023-03-27
SYNERGIAS
Grupo Espanol de Investigacion en Sarcomas
Phase 2
Unknown
85 enrolled